Incyte Commits $900M to MorphoSys for Rights to Lymphoma Drug

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Jan 14, 2020 at 12:42 AM.

  1. #1 cafead, Jan 14, 2020 at 12:42 AM
    cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    33,024
    Likes Received:
    3
    via Two weeks after MorphoSys filed for FDA review of its experimental treatment for a form of lymphoma, the company has struck a deal with Incyte to further develop and commercialize the therapy in the US and around the world.

    article source
     
    Quote

Reply to Thread